J o s e p h S t a n l e y M i t c h e l l was b o rn in B irm ingham on 22 Ju ly 1909, the eldest of th ree child ren b o rn to Joseph B row n M itchell and Ethel M aud M ary A rnold, b o th of w hom w ere schoolteachers and for w hom education was always of p rim e im portance.
th eir fam ilies, Joseph and his tw o younger sisters w ere no strangers to the problem s of fam ilies living u n d e r the stress of poverty and this clearly influenced his fu tu re th o u g h ts and sym pathies tow ards u n stin tin g service to those less fo rtu n ate th a n him self.
H e felt th a t his hom e had a feeling of poverty (indeed he recalls receiving a boot and clothing allow ance from a local charity) b u t this probably reflects m ore the care w ith w hich his hom e was m anaged d u rin g the w ar years of 1914-18 th a n of any real h a rd s h ip ; for security, affection and the availability of m any and varied books seem to have been m uch m ore ap p aren t th a n poverty. M oney was never gru d g ed for educational use such as the purchase of Am ateur , A rth u r M ee's Children's Newspaper, Country Life and the Smallholder. W ith the fam ily devoted to teaching, th ere was always m ore th an enough to fill the days of the week, and Sundays, th o u g h respected as a day of rest, w ere not th e penance suffered by m any. T h e fam ily w orshipped at several of the local church es and non co n fo rm ist chapels, read the classics together (suitably abridged to retain interest), en tertain ed friends to tea and w ent for long walks, d u rin g w hich Joseph becam e greatly interested in butterflies. D u rin g these walks, too, his father used to set him problem s in m ental arithm etic, the solutions to w hich were invariably followed by 'N ow ask m e a n o th e r'.
Joseph inh erited m uch of his parental and g ran d p aren tal interests, w hich w ere stim ulated by fam ily conversation and by his early teaching, w hich took place at hom e. H e was reading G a n o t's Physics by the tim e he was eight, becom ing interested in experim ents (he early rigged up m irro rs so th at he could see ro u n d corners) and avidly absorbing sim ple everyday science principles involving solution, suspension, crystallization and germ ination, to w hich he was in tro d u ced by his m o th er. H e was naturally endow ed w ith accurate p ercep tio n and the ability to th in k deeply for his age and was never satisfied w ith m ere superficial know ledge.
T h e fam ily m oved to A dcock's G reen in 1922, an area chosen for its closeness to the countryside w hile being still w ith in the B irm ingham C ity b o undary, so retaining the advantage of the scholarships aw arded to C ity residents.
In his childhood, he was m uch influenced by a local vicar, C anon G o n n er (born in G erm any), w ho gave Joseph m any of the toys and books th at had belonged to his sons killed in the 1914-18 w ar while fighting on the Allied side. T h ese not only stim ulated his interests b u t also left him w ith a deep feeling about the folly of w ar. A few years later he took up a constructive interest in elem entary w ireless sets, aided by the weekly Amateur W i r e l e s s , and his sisters helped w ith the w inding of copper coils for hom e-m ade rheostats and condensers. W ith earphones they w ere able to pick up 2L O , on occasion Spain, and tu n e d in to the opening of the W em bley E xhibition and the voice of E rn est L ough. L ittle patience was show n to anyone w ho shook the c at's w hisker in those days.
N a tu ra l h isto ry was sim ilarly encouraged by his p aren ts so th at Joseph had a large co ld -w ater a q u ariu m and a te rra riu m , and the fam ily kept a w hole range of anim als and insects collected by n e t-d ip p in g in th e local clay p it and canal. A n especial in terest was L ep id o p tera, w hich involved m o th -w a tc h in g by th e light of torches and it is typical th at, in later years, he deeply reg retted his collections as they had involved the killing of living system s. H e retain ed this enthusiasm and, to the end of his life, could accurately identify a tiny scrap of flu tterin g colour m any yards away. In fre q u e n t fam ily holidays, usually w ith relatives in the country, w ere th e occasion for the study of fossils, old buildings and castles, know ledge th a t was su p p lem en ted on th e ir re tu rn by visits to local reference libraries and m useum s. O n one of these holidays they w ere able to w atch a p air of kingfishers rearing th e ir young and w ere in tro d u ced to p h o to g rap h y . N atu rally they did th e ir ow n developing and p rin tin g .
As far as o th er p u rsu its w ent, long walks and sw im m ing w ere the m ain physical ones, w ater-colours, carp en try (helped by an uncle) and the piano ro u n d in g o u t a childhood exceptionally stron g in intellectual stim ulation.
T h e attic in his hom e was converted into a study for Joseph, and his yo u n g er sister records as one of her earliest m em ories the sound of Jo se p h 's alarm clock going off at 5 a.m . so th a t he could begin his studies.
In 1921, after atten d in g Y ardley R oad H igh School, he w on an en tran ce scholarship to K ing E dw ard V I H igh School in B irm ingham w here he com pleted his secondary education, on the classical side u n til the last tw o years. T h e w ide interest th a t he developed in languages, in clu d ing G reek, S anskrit and G erm an, always rem ained w ith him and he records the d eb t he ow ed to another clergym an, the Rev. N o rm an O rr, w ho helped him study the G reek T e stam en t as well as developing his concern for social problem s. B ut it was obvious th at Joseph was in terested in a scientific career and he was fo rtu n ate th at he came u n d er the influence of an unusually stim ulating biology teacher, H . W . Ballance, w ho in tro d u ce d him to the m odern ideas in plant physiology and b iochem istry. H e w on a S tate S cholarship to B irm ingham U niversity w here, in 1926, he began his preclinical studies. A lthough his own in terests w ould pro bably have led him to m edicine in any event, the suffering of a near neig h b o u r in the term inal stages of cancer was an added sp u r in the direction in w hich he was to specialize. T w o years later he was still of an age to sit for and w in an E ntrance Scholarship to St J o h n 's College, C am bridge, w here he took a F irst Class in each p art of the N atu ral Sciences T rip o s, specializing in Physics in P art II and, as advised by his tu to r, passing the necessary exam inations in pre-clinical subjects so th a t he could take the C am bridge M .B. after com pleting the necessary clinical years at B irm ingham . (In those days all C am bridge m edical stu d en ts had to go elsew here for clinical instru ctio n .) H e won m ost of the available prizes at B irm ingham , graduated M .B ., B .C hir., at C am bridge in 1934 and, after the usual H ouse jobs, was aw arded a Beit M em orial Fellow ship in M edical R esearch at the Colloid Science L aboratory in C am bridge u n d er the supervision of E. K . Rideal, F .R .S .
H is m arriage to D r Lilian M ary B uxton in 1934 jo in ed him to the person to w hom he always paid the trib u te th at she was by far the greatest influence on him both in his scientific and personal life. T h e financial security afforded by her fam ily business, in w hich M itchell took a great interest until shortly before his death, m eant th a t he could always take w hatever job seem ed to th em to be best suited to his chosen career. H er calm and peaceful personality bo th shared his scientific interests and helped him shed some of the w orries th at continually beset him . T h ey becam e uncannily close even to the extent of dream ing the same dream d uring the same night and w ere totally consistent w hen dealing w ith th eir tw o children, w ho grew up in an atm osphere w here work was w holly im p o rtan t and m ust N O T be in te rru p ted by noise. H er unexpected death in 1983 was a severe shock to him .
H is first research project, ' Irrad iatio n of th in protein film s', led to his P h .D ., to a Research Fellow ship at St J o h n 's College, and form ed the base from w hich he developed the researches in w hich he spent the rest of his life. It also lead, in due course, to his buying * T h o rn d y k e ' the large house on H u n tin g d o n Road, C am bridge, for this belonged to Rideal while Joseph was his research student. A fter he becam e a professor all his friends and collaborators w ere invited to a p arty every Boxing D ay at 'T h o rn d y k e ' and Joseph often m entioned how unlikely it w ould have seem ed to him then th at he w ould one day live in R ideal's house.
H e then retu rn ed to clinical w ork in radiotherapy, first at the C hristie H ospital and H olt R adium In stitu te in M anchester and then, in 1938, at C am bridge as A ssistant in R esearch in R adiotherapy in the D e p artm en t of M edicine u n d e r J. A. Ryle, w ith clinical facilities in A ddenbrooke's H ospital w here he was p u t in tem porary charge of X -ray and R adium T h erap y . T h is position was m ade p erm an en t in 1943 w ith the form ation of the new R adiotherapeutic C entre at A ddenbrooke's. St J o h n 's College renew ed his R esearch Fellow ship for a fu rth er period and by the end of W orld W ar II he had becom e an Official Fellow, w hich he rem ained for the rest of his life. A lthough he was therefore a Fellow for nearly 50 years, the extent of his other com m itm ents did not allow him tim e to take a pro m in en t p art in College life.
In 1944, Sir John C ockcroft sum m oned M itchell to Chalk R iver in C anada both to look to the radiobiological hazards to the health of those w orking w ith radiations and to advise on and direct a com prehensive m edical program m e. O riginally there had been full collaboration w ith the A m ericans on all aspects of atom ic energy, b u t this ceased ab ru p tly as soon as the A m erican pile started operating in 1942, and although the M anhattan Project had set up a H ealth D ivision by 1942, owing to this lack of collaboration M itchell had to start the H ealth D ivision at Chalk R iver m ore or less from scratch, so th a t m uch of his tim e was taken up w ith ro u tin e m atters of health and p rotectio n of the staff engaged in rad iation w ork. H e took all these m atters very seriously and appeared w eighed dow n w ith w orry to the extent th a t he always seem ed m uch older th an he was. B elieving th a t the greatest hazard in the developing nuclear field at th a t tim e was the effect of radon on u ran iu m m iners, he cam paigned vigorously and successfully to reduce the u p p er dose lim it of 0.1 rem s p e r day (acceptable in 1945) to the p resen t lim it of 5 rem s per year. H is recognition of this hazard led him to som e early theoretical w ork on suitable g am m a-em ittin g p ile-p ro d u ced isotopes th a t m ight replace rad iu m as a m edical tool.
A fter th e Q uebec conference, the C halk R iver project was given the task of exp loring th e possibility of a heavy w ater reactor and the p ro d u ctio n of th e fissile isotope uran iu m -2 3 3 . In those days, the N ational R esearch C ouncil of C anada (w ho ran the C halk R iver Project) was still operating w ith th e m en tality of the depression of the 1930s (fear of over-expansion, low salaries, low budgets)-views u n d e r w hich M itchell naturally chafed. H ow ever, w ith G . C. B utler he outlined the directions in w hich radiobiological research should go and these pathw ays are still being follow ed today. T h ese included the study of the m echanism of action of various types of radiation on the fundam ental biochem ical processes in cells, w ith special em phasis on nucleic acids and nucleoproteins and the developm ent of techniques to use p h o sp h o ru s-32, n itro g e n -15 and c a rb o n -14 to study norm al and p e rtu rb e d m etabolism , including resp iration. A proposal to elucidate the chem ical m echanism s of early rad iation effects was an o th er am bitious und ertak in g , as was the study of the genetic consequences of radiation dam age.
In these, as in all o th er aspects of radiation biology and radiation m edicine, M itchell was a generation ahead of his tim e, his ability to take a bro ad view of fu tu re developm ents being m ade possible by a polym ath approach to science. H e never hesitated to take up (and m aster) new subjects if he needed them to pu rsu e his researches.
H e re tu rn e d to C am bridge at the end of 1945 and was appointed to the new ly form ed C hair of R adiotherapeutics, and w ith it the H onorary D irecto rsh ip of the R adiotherapeutic C entre at A ddenbrooke's H ospital.
M itc h ell's m ain interest was always prom inently displayed on a notice at the entrance to his laboratories: 'T h e aim of this D ep artm en t is to im prove the tre a tm e n t of c a n c e r', and it is by this criterion th at he will be rem em bered. A lthough the n u m b e r of his publications reflects the large p ro p o rtio n of his tim e th a t he gave to the patients who came for tre a tm e n t to the R adiotherapy C entre at A ddenbrooke's H ospital in C am bridge, had there been m ore hours in the day he w ould still have felt th a t his patients deserved a high p ro p ortion of them .
W orking firstly in a converted house on T ru m p in g to n Street, then in som e p refabricated hu ts on the D ow ning Site, he collected together a band of colleagues from a diverse range of specialities dem o n stratin g a form idable know ledge in all of them . In due course, the M edical R esearch C ouncil provided a m ore suitable bu ild in g th a t housed p art of the d ep artm en t until m ost of it m oved to the N ew A d d en b ro o k e's site, w here he rem ained w orking until a few weeks before he died. B ut never was the whole d ep artm en t able to w ork u n d e r one roof and rig h t up to the end, w hen the U niversity D e p artm en t was closed dow n on M itch ell's retirem ent, they w ere still ru n n in g a m in i-b u s service betw een the various sites.
D u rin g the 1950s in C am bridge there existed an unofficial body irreverently know n as the 'Bad B oy's C lu b ', w hose object was to bring pressure to bear on the central bodies and th eir com m ittees w ho, at th at tim e, w ere able to dictate the directions in w hich the U niversity was to develop. T h e ' C lub ', lim ited to the heads of large d ep artm en ts, consisted of Sir Alex (later L ord) T o d d , Sir Jo h n Baker and Sir Jo h n L en n ardJones. M itchell was invited to jo in them as the only professor of clinically orientated m edicine o th er than the Regius Professor (S ir Lionel W hitby) who, as the H ead of a College, was considered to be p art of the establishm ent. M itchell proved sym pathetic to th eir aims and gave the C lub his full support, as he did tow ards the prospect of any collaboration betw een the m edical and purely scientific dep artm en ts.
M itchell never found the U niversity authorities easy to get on w ith. Back in 1945 C ockcroft had been prepared to give them a reactor b u t the U niversity tu rn e d it dow n. A nd later, if the U niversity had show n any interest, a research reactor could have been m ade available from governm ent funding. All this caused him considerable exasperation and he used to drop in to have tea w ith Sir G eorge G odber, then the C hief M edical Officer in the M in istry of H ealth, to talk over problem s th at he felt could not be kept confidential if he talked th em over in C am bridge.
In 1956 Sir L ionel W hitby, the adm inistrative head of the M edical School (the Regius Professor of Physic) died unexpectedly, and a new Regius was needed. O utside candidates were difficult to attract because the holder w ould have to give up private practice. As one of the few m edical professors in the U niversity, M itchell was clearly a possible choice b u t he m u st have had some hesitation in accepting a position involving a great deal of adm inistration (w hich never came easily to him and w hich drastically lim ited the tim e he had left after fulfilling his clinical responsibilities). B ut he doubtless felt th at the titu lar head of the M edical Faculty m u st be som eone com m itted, as W hitb y had been, to the form ation of a School of Clinical M edicine in C am bridge.
T h e T o d d report on clinical education had found th at the C am bridge pre-clinical d epartm ents were o rientated w holly tow ards the sciences and paid little or no regard to the training of m edical practitioners as such. Indeed, the U niversity as a whole was distinctly lukew arm in its attitu d e tow ards the proposed Clinical School, M itchell and H . R. D ean (the P ro fessor of Pathology, th e n over 80 years of age) being alm ost alone in th e ir stro n g su p p o rt.
M itch ell held th e R egius chair u n til he retired from all clinical and a d m in istrativ e w ork to give the w hole of his tim e to a co n tin u atio n of his research into radioactive drugs. A lthough, like m ost clinicians, he felt the loss of his contacts w ith p atien ts, he felt som e relief in the cessation of his deep involvem ent w ith th em , w hich had always been a considerable drain on his em otional resources.
H is w ork w ith the A tom ic E nergy projects was recognized by the aw ard of the C .B .E . in 1951 and, ap art from the Fellow ship of the Royal Society, he derived m ost pleasure from his h o n o rary D .S c. from B irm in g h am U n iversity. A m ong his m edical degrees he listed fellow ships of th e Royal C olleges of R adiology, Physicians, and S urgery. H e was an H o n o ra ry M em b e r of the G erm an R oentgen Society, received the P iro g o ff M edal from th e U .S .S .R . A cadem y of M edical Sciences and was d elig h ted to be th e F o u n d e r P resid en t of the B ritish Section of the A nglo-G e rm a n M edical Society, w hich he addressed in a G erm an gram m atically co rrect even if unlikely to be taken for his native tongue.
S c i e n t i f i c w o r k
M itc h e ll's early p ublications provide indicators to the criteria th at were to govern his approach to b o th clinical and research w ork for the rest of his life. H is first paper, p u b lish ed in the Philosophical M agazine in 1932 (1)# , was a m athem atical note on H u y g e n s's Principle and his potential as a m athem atical physicist was again d em o n strated in a p ap er in the follow ing year on th e ' D iam agnetism of free e le c tro n s' (2). A lthough these are his only publications of a purely theoretical n atu re, they are an in d ication of M itc h e ll's im m ense intellectual b read th . T h e re seems little d o u b t th a t, had he so w ished, he could have m ade im p o rtan t co n trib u tio n s to th eo retical physics.
By 1934 M itchell was already dem onstratin g , in his first clinically related p ap er on ' Som e aspects of the chem istry of haem atocolpos fluid ' (3), th e critical analysis th a t was to characterize his w ork for the next 50 years. H e suggested th a t a sim ple physio-chem ical m echanism could explain th e elevated calcium levels in haem atocolpos fluid previously assum ed to be due to a process of active secretion. As a result of his strong fo u n d ations in physical science he was rarely to p u b lish a paper in w hich th e possible m echanism s involved w ere not considered in detail.
In his first case rep o rt p u b lished in the Lancet in 1935 (4), M itch ell's c o m m itm en t to m eticulous attention to clinical detail was also clearly d em o n strated .
Biophysics of monolayers and the biological effects of ultraviolet light
A bout this tim e there began a period of very fruitful research in m onolayer biophysics u n d er the guidance of Professor E. K. Rideal. M itchell tackled problem s relating to the properties of m onolayers th at m ust have seem ed form idable at that tim e, for exam ple the absolute q u antum efficiency of the photochem ical hydrolysis of m onolayers of stearic anilide; correlation of the surface potential in m onolayers w ith surface pressure and dipole m o m e n t; and the stru ctu re of protein m onolayers.
A m ajor paper published in 1937 (8) on 'Photochem ical reactions in m onolayers' shows that, in addition to being a sound theoretician, M itchell was also a good experim entalist. T h e paper contains a detailed account of the production of m onochrom atic ultraviolet light by using a quartz crystal th at was capable of providing uniform irradiation over a wide aperture, a necessary requirem ent for the study of m onolayers. T h e paper also contains a careful account of the m easurem ent of u.v. light intensities by using an actinom eter, an aspect of m etrology th at is still not easy even w ith m odern technology. T h e eq u ip m en t was used to study the photochem ical behaviour of the C O -N H linkage in relatively sim ple com pounds, especially in those containing an arom atic chrom ophore, as a precursor to an investigation of the m echanism of action of ultraviolet light on proteins. T h is w ork dem onstrated the im portance of m olecular orientation in controlling the rate of the photochem ical reaction, and a sem i-quantitative theoretical in terpretatio n was given of the observed variation of apparent q u an tu m efficiency w ith m olecular area.
Some of M itchell's related publications give fascinating indications of the future. F or exam ple in a note to Nature (9) he reported th at the chem ical properties of m onolayers of w idely different com pounds could be 'profoundly m o d ified ' by the presence of extrem ely small traces of active substances including m etallic ions. T h is was 'noted to be probably of great biological significance'. In a fu rth er paper on the stru ctu re of protein m onolayers (11), analogies w ere draw n betw een the m onolayer form ed on an aqueous m edium and the evidence beginning to accum ulate at the tim e th at natural m em branes consisted of th in lipoid layers on to w hich were adsorbed m onolayers of proteins, w ith th eir n on-polar side chain in the hydrocarbon layer and th eir polar com ponent in the aqueous m edium . It was also noted th a t there were significant differences in the surface spreading properties of tw o sam ples of cystalline insulin, although no fu rth er details were given about their (separate) origins. T hese papers show a willingness to use a degree of sophistication in physical m ethods to attack biological problem s th at was not to becom e fashionable un til the developm ent of m olecular biology some 20 years later. M itchell's first reference to m alignant disease appears to be in a short com m unication to the l l e Congres International de Lutte Scientifique et Social contre le Cancer held in B russels in S ep tem b er 1936 (12) w here he had b een quick to appreciate the relevance of his ow n w ork to ' the recent findings th a t m alig n an t neoplasm s could be provoked w ith considerable certain ty by u ltrav io let lig h t'.
In 1938 (14) M itchell p u b lish ed a m ajor p ap er on 'T h e origin of the e ry th em a curve and the pharm acological action of ultrav io let radiation. ' In it h e: (i) review ed the m easu rem en ts of th e erythem a curve and relev an t know n facts on th e reaction of h u m an skin to ultraviolet lig h t; (ii) developed a theoretical m odel for a possible photochem ical m ech an ism ; (iii) p resen ted q u an titativ e evidence th a t erythem al response is due to p h o to -d eco m p o sitio n of p roteins, w ith a laten t p eriod th a t is at least in p a rt due to the tim e taken for diffusion of active p h o to d eco m p osition p ro d u c ts to m in u te v e sse ls; (iv) calculated the m ean value for th e w avelength of m axim um erythem al efficiency and d em o n strated th a t it was in close agreem ent w ith ex p erim en t; (v) show ed th a t the know n m in im u m ery th em a dose was consisten t w ith th e form ation of p h o to -d eco m p o sitio n p ro d u c ts in vitro at con cen reasonable o rd e r of m ag n itu d e for the observed effe ct; (vi) discussed the relatio n ship of e ry th rem o rp h o g en esis to pigm en tatio n and carcinogenesis by u ltrav io let light.
T h is p ap er n o t only placed in perspective the inform ation know n at th a t tim e on th e action of u ltraviolet on th e skin, b u t also d em o n strated M itc h e ll's ability to stu d y a com plex biological p ro b lem from b o th the th eo retical and experim ental view points, th ereb y greatly enhancing u n d e rsta n d in g of th e m echanism s involved.
In 1939 M itchell p u b lish ed in Tabulae Biologicae a com pilation of all th e d ata available up to th a t tim e on th e colloidal p ro p erties of the cell (15). Sections w ere devoted to th e tension at the surface of living cells, the b o u n d a ry state (including liquid-liquid interfaces, air-w ater interfaces, p ro te in m onolayers, m olecular interactions at interfaces and chem ical reactions in m onolayers) and the viscosity of cell contents. A lthough m u ch of th e data is now o u t of date it was a rem arkable w ork at the tim e, con tain ing 382 references and d em onstratin g an o th er of M itch ell's e x trao rd in ary sk ills: an ability to search the literatu re in the m in u test detail for articles of relevance to a particu lar subject and th en to co o rd in ate th em into a com prehensive review of the cu rren t state of know ledge on th a t subject. T o the end of his life M itchell could always be g u aranteed to have read and digested all the latest literature, and little m ore th a n a m o n th before his death he was still bringing recently p u b lish ed im p o rtan t new m aterial to the atten tio n of younger colleagues, often before the relevant issue of the jo u rn al had appeared in the Clinical School L ib rary .
Radiobiology and radiotherapy technique
M itch ell's first paper on ionizing radiations was a note to Nature (16) on the effect of w avelength on the reaction of h u m an skin to X -and gam m a-radiation. It m akes strange reading now w ith w avelengths expressed in X .U . and the specific gam m a-ray activity of radium in Im c.hr. Even the R ontgen is no longer in vogue. By careful dosim etry he concluded th at the doses of X -and gam m a-rays req u ired to cause m oist desquam ation were not the same, one of the first experim ents to dem onstrate differences of radiobiology effectiveness on h u m an tissues for different radiations. T h is paper concluded * C om parison of the relative biological effectiveness (RBE) for norm al and neoplastic tissues w ould be of great radiotherapeutic in te re s t', a concept th a t still dom inates the thinking of m any radiobiologists to this day.
A fter an enforced w artim e gap, ano th er im p o rtan t paper on R .B .E. appeared in 1947 (31). In experim ents on the m echanism of the biological action of fast neutrons, by using the sum m ation m eth o d for lethal effects in mice, it was show n th a t there was a m uch higher R .B .E . for n eu tro n s (32.0 ±8 .6) w hen the m ean overall exposure tim e was 48 hours, com pared w ith the previously obtained figure of (7.5 2.5) w hen the exposure tim es were of the order of 10 m inutes to 1 hour.
C om paring the effects of n eu tro n and gam m a-radiations M itchell also found a significant d ep artu re from additivity, suggesting different m echanism s of action. H e stated, 'T h is result appears to be in disagreem ent w ith the experim ents rep o rted by Stone ' (who had concluded th at the effects of fast n eutro n s and gam m a-rays were totally additive and th at slow n eutrons and gam m a-rays were likely to show alm ost com plete additivity). A lthough M itchell tentatively attrib u te d the different m echanism s to differences in the actions of the radiations on proliferating cells, w hereas subsequent w ork has show n cellular recovery to be the m ost im p o rtan t single factor, this w ork probably convinced him th at there were im p o rtan t m echanistic differences betw een the actions of neutrons and gam m a-rays and may have prevented him from following S tone's p rem ature intro d u ctio n of n eutro n s into radiotherapy (w hich was responsible for several radiation-induced deaths).
In 1946 of these radiations (52). M itchell also m ade an estim ate of the R .B.E. of the gam m a-rays from a short-d istan ce irid iu m -192 gam m a-ray therapy u n it developed in his d e p artm en t (61). W ith his concern for reducing radiatio n hazards he soon realized th a t the su b stitu tio n of caesium -137 for rad iu m in the tre a tm e n t of cancer of the cervix could lead to the developm ent of a sim ple after-loading technique (98), w hich was a fo reru n n e r of the system now w idely m arketed by A m ersham In tern atio n al.
Radiation hazards
In 1944, w hen M itchell was in charge of m edical investigations at the B ritish and C anadian A tom ic E nergy Project in M ontreal, he was p articu larly concerned w ith radiation hazards. A n im p o rtan t task th at he tackled was to establish provisional values for the m axim um perm issible fluxes of fast and therm al n eutrons, taking into account all the experim ental evidence available at th a t tim e (26, 28, 40) . H e also assessed the risks of internally ingested radionuclides such as p h o sp h o ru s-32: used th erapeutically since 1936, and likely to becom e readily available in the im m ediate p ost-w ar period from the nuclear reactors. M itch ell's approach was cautious. In 1947 he felt th at the clinical use of 32P was only of real value in the tre a tm e n t of polycythaem ia vera, and that, because of the p o tential genetic and lo n g -term effects, it should no t be used in patien ts w ho w ere in the reproductive period of life or who had an expectation of life of five years or m ore (33). H e was sim ilarly cautious in his approach to the use of iodine-131 (39). H is anxieties about the long term carcinogenic effect of radiation w ere reinforced by a patient seen in 1948 w ith a skin cancer alm ost certainly arising from a single diagnostic X -ray exposure 49 years previously (51).
M itchell was an active m em ber of the M .R .C . com m ittee on the hazards to m an of nuclear and allied radiation, w hich reported in 1956 (58). H e was also closely involved w ith investigations into the late effects of T h o ro tra st, a colloidal solution of th o riu m dioxide once used as a radiographic contrast m edium (100, 101).
Therapeutic use of radionuclides
By 1945 it was clear that, after the war, a B ritish A tom ic A uthority w ould be set up w ith its ow n reactors and M itchell chaired the com m ittee th at decided w hich radioisotopes should be produced by the reactors for m edical applications, how, and in w hat quantities. T h is involved an im m ense am ount of theoretical work and it is clear th at his advice in these m atters has stood the test of tim e in th at he suggested practically every isotope th at has proved to be of m edical use up to the present (24, 27, 29) . H e was one of the first to recognize th at cobalt-60 would be a very suitable gam m a-ray source for radiotherapy and it was therefore fitting th at nearly 40 years later he helped com pile a W orld H ealth O r g an izatio n -In tern atio n al A tom ic E nergy A u th o rity publication on the practical use of cobalt-60 teletherapy m achines (112). H e already realized th at the existing m ethods of radiotherapy suffered from severe lim itations of non-specificity and was beginning to consider how possibly to localize radiation effects and w hether biochem ical selectivity could be used to concentrate radiation em itting m aterial. H e closely studied the internal use of the then available radionuclides (39) and by now was considering the possibility of suitably labelled com pounds th a t w ould concentrate selectively in tum ours, a forecast of his later experim ental and clinical w ork w ith labelled synthetic vitam in K su b stitu te (Synkavit).
Metabolic effects of r a d i a t i o n , radiosensitizers and the radioactiv
H is co n tributions to our clinically orientated know ledge of the m echanism of action of ionizing radiations continued w ith the d em o nstration (17) th at doses in the therapeu tic range caused an increase in the am ount of ultraviolet absorbing m aterial in the cytoplasm of biopsy specim ens from patients undergoing treatm en t. T h e m easurem ents were rigorously controlled by experim ental techniques th at only a clinician w ith research experience in physics and physical chem istry could have applied. T h e accum ulating m aterial gave some of the reactions to be expected of pentose nucleotides and was definitely no t D N A . T h e re was no obvious correlation betw een the clinical response and the changes in U .V .-absorbance of the cells. T h ese findings w ere fully rep o rted in th ree papers in 1942 (18-20) entitled 'D isturb an ce of nucleic acid m etabolism p roduced by therapeutic doses of X -and gam m a-radiation ' in w hich he confirm ed th a t the accum ulating m aterials w ere indeed pentose n u c leotides and th at the synthesis of D N A in the nucleus was inhibited. T h is was followed by a sh o rt com m unication (21) in w hich he used the same techniques on chick fibroblasts grow ing in culture. Som e tim e later he reported (58, 89) th a t the dam age to D N A or D N A -p ro te in (w hich he referred to as a m acrom olecular lesion) could be observed w ithin m inutes of the end of irradiation.
H is next paper (22) b ro u g h t some ord er to the field of the m etabolic effects of ionizing radiation by em ploying a quantitative physico-chem ical concept of ionic efficiency-the n u m b er of m olecules affected (accu m ulating or the form ation of w hich is inhibited) p er ion pair to provide a link betw een the dose and the biological effect. Review ing some of the extensive literature in the field in the light of this concept he calculated th at the ionic efficiency for the inhibition of D N A synthesis (as show n by studies of the d istrib u tio n of p h o sp h o ru s-3 2 and of uric acid accum ulation in an experim ental anim al tu m o u r) was of the same o rder as th at for the inhibition of glycolysis and th a t enzym e inhibition was a likely com m on factor.
In 1947 he published his first paper (w ith I. Sim on-R euss) (30) on the effect of therapeutic doses of X -rad iatio n on cultures of norm al cells and on h u m a n m alig n an t cells p re tre a ted w ith a synthetic vitam in K su b stitu te m ark eted by R oche P ro d u cts (Synkavit). H e chose this co m pound (2 -m e th y l-1,4 -n a p h th a q u in o l bis (disodium phosphate)) from the B ritish P h arm acopoeia because it was a w ater-soluble no n -to x ic co m p o u n d of a size sim ilar to a pentose nucleotide, and w hich w ould have potential o x id a tio n /re d u c tio n characteristics u n d e r m etabolic conditions (w hen th e labile p h o sp h ate g roups w ould uncover a q u in o n e /q u in o l system ). By m easu rin g th e percentage of cells in the cu ltu re un d erg o in g m itosis at various tim es after tre a tm e n t, he was able to show th at the cultures tre a ted w ith Synkavit alone show ed 30.7 % in h ib itio n , w ith X -rays alone 35.1 % in h ib itio n , w hereas the com bination gave 8 6 % inhibition. T h e calculated value if the tw o agents w ere acting in d ep en d en tly was 55 % in h ib itio n . A lthough no th erap eu tic value was claim ed, histological evidence from som e of the 25 cases treated w ith a com bination of Synkavit and X -rays was p resen ted (and confirm ed later (36) on a d ifferent m alignancy) th a t was n o t inconsistent w ith the laboratory findings.
T h e re a fte r, w ith few exceptions, his publications represen ted a refinem ent and extension of this a tte m p t to im prove the treatm en t of cancer by the use of chem ical agents to poten tiate th e desired effect of ionizing radiations, and because m ost of his laboratory w ork was so closely linked to clinical observations they will n o t be separated in this m em oir.
H is next p ap er (35) described the first clinical trial of the com bined th erap y on 116 p atien ts betw een 1946 and 1948. T h e problem s of setting up an ethically acceptable trial on patients suffering from a potentially fatal disease and the tim escale involved in p ro d u cin g a statistically significant result w ere becom ing clear, as was the extrem e im portance of elim in ating any system atic errors. A n interestin g clinical observation was th at, sh o rtly after the injection of Synkavit, several p atients noted pain, som etim es severe enough to w arrant m edication, at the site of the tu m o u r especially w hen the com pound was given intravenously. In this trial the results obtained from a sm all group of histologically proven cases of carcinom a of the b ro n ch u s show ed th at the com bined th erap y gave a palliative response resulting in a small increase in useful survival tim e after tre a tm e n t, later confirm ed over a longer period (46).
In 1952 (w ith I. S im on-R euss (41)) he rep o rted fu rth er studies to d eterm in e the m ode of action of Synkavit as an in h ib ito r of m itosis and radiosensitizer of cultures of norm al chick fibroblasts. T h e m ost satisfactory q u antitative approach was to define a potentiation factor by m easuring the effect of the com bination of one half of th at dose of each agent th at, by itself, w ould produce a 50% inhibition of m itosis. T h u s Synkavit at 3.81 x 10~6 M or 315r each separately caused 50 % inhibition, w hereas the com bined effect of one half of the dose of each agent gave 8 3 .8 % inhibition.
T h e p aper stressed th a t inhibition of m itosis per se was probably not the m ost im p o rtan t factor in clinical retrogression of a tu m o u r, th at of chrom osom e breakage and recom bination being probably m ore so, and th at there was an increase in these effects too in the treated cultures. It seem ed reasonable, therefore, to look for a radiosensitizing effect in different com pounds that, by them selves, caused increased chrom osom e dam age in treated cultures. A subsidiary finding, th at am poules of Synkavit incubated at 37 °C show ed progressive loss of radiosensitizing action, was of obvious im portance in attem p ts to reproduce these results, let alone clinical ones th a t w ere statistically less obvious. T h e cytological effects of some 29 related com pounds investigated (42) suggested th a t three types of action m ight be involved in rad io sen sitizatio n : blockage of the entry of cells into m itosis, m etaphase arrest and spindle abnorm alities (rem iniscent of the effect of colchicine), and chrom osom e breaks caused directly by the passage of an ion pair or indirectly by the im p airm en t of D N A synthesis. In this context it is interesting th a t a later paper (66) reported th at vitam in K l, w hich show ed no effect by itself on chick fibroblasts, potentiated the effect of X -rays by a factor of betw een 3 and 4 as m easured by m itotic inhibition although it was no t able to sensitize the W alker rat carcinom a (67). A paper on related laboratory studies (47) show ed that, after intravenous injections of small doses of Synkavit into a rat bearing a tran sp lan ted tu m o u r, som e organs, especially the kidney and the grow ing edge of the tu m o u r, show ed a b rig h t yellow fluorescence w hen viewed u n d er ultraviolet light (an effect increased if the sections w ere first treated w ith an alkaline solution of hydrogen peroxide and show n m axim ally some 30 m inutes after the injection). T h e fluorescence sp ectru m was identical w ith th a t of the 2 :3 oxide of 2 -m e th ly -l,4 -n a p h th aq u in o n e and this finding, w ith the reports of focal pain m entioned above, w ere the first indications th a t Synkavit m ight be selectively taken up by tu m o u r cells and th at if this w ere so, it m ight becom e possible to use Synkavit incorporating a radioactive isotope as a m eans of delivering a dose of ionizing radiation to the tu m o u r cell while, at the same tim e, sensitizing the cell to the radiation. T h is led to the concept of the 'radioactive d r u g '.
T h e com pound 2,3 -d im eth y l-1,4-n ap h th aq u in o l bis (disodium phosphate), earlier identified as w orth fu rth er study (42), show ed sim ilar evidence of radiosensitization w hen tested for its ability to cause p erm anent retrogression of the W alker rat 256 carcinom a: dim ethyl com pound Synkavit retrogressions in control group retrogressions from intravenous com pound retrogressions from llOOr X -rays retrogressions after com bined treatm en t 0 /9 3 3 /7 8 2 /9 4 6 /7 9 33/87 32/78 52/93 52/77
T h e tim ing of the injection of the sensitizer (30 m inutes before radiation) was critical and was chosen as a result of the fluorescence experim ents already m entioned.
T h e retrogression rate resulted from the com bined treatm en t w ith S ynkavit could also be achieved by a dose of 1400-1500r alone so th at th ere was evidence of a 40 % increase in the biologically effective dose. It was later n o ted (67) th at, in this experim ental system , it was no t possible to increase fu rth e r the effect of the higher dose by Synkavit treatm ent, n o r did Synkavit tre a tm e n t sensitize the anim al to w hole body radiation (50).
C o n tin u ed consideration of the design of a clinical trial in patients w ith m alig n an t diseases lead him to w rite the following paragraph, w hich is w o rth q u o tin g in full:
In general, in considering therapeutic trials in the cancer field, the design must be capable of giving a completely convincing statistically significant quantitative result as efficiently as possible with a minimum number of patients, and must be acceptable and above reproach from the moral and ethical points of view. The most important single feature of the design is random allocation of patients to two (or more) alternative forms of treatment, the value of which is being compared. For assessment of the results of treatment it is necessary to select relevant criteria capable of objective measurement such as the survival time suitably specified. At the same time, it is absolutely essential to provide for each individual patient that form of treatment which is the best possible according to the present knowledge at the beginning of the investigation. Accordingly, it will often be necessary to plan to depart from what might be termed the theoretically ideal form of experiment with deliberate sacrifice of some information.
F o r a m easurable effect, it is reasonable to require th at a new form of tre a tm e n t should double the expected survival tim e from first treatm ent and the p atients should, ideally, be followed up for at least four tim es the m ean survival tim e. G iven, in addition, the tim e req u ired to collect an adequate n u m b e r (say 200) cases it becom es clear th at properly controlled clinical trials in this field require conditions such as histologically proven, inoperable carcinom a of the bronchus (59). A later rep o rt ((77) w ith D . B rinkley & J. L. H aybittle) studied the effect of radiation w ith Synkavit a n d / or oxygen and concluded th at the small palliative response show n by Synkavit was n o t increased by oxygen, w hich, by itself, showed no radiosensitization.
In a paper delivered at the R adiobiology Sym posium in Liege in 1954 (50) M itchell reported on a series of experim ents by I. Sim on-R euss that show ed th at the radiosensitizing effect of a single treatm ent by Synkavit on cultures of chick fibroblasts was still apparent after the culture had been su b -cu ltu red for up to 17 passages over a period of 5-6 weeks. F u rth er, th at the sensitizing effect could be shown after a single treatm ent at concentrations as low as 10-10 M , w hich by them selves had no m easureable effect on m itosis. In the same paper he suggested th at the radiosensitizing effect m ight be due to the liberated quinone reacting w ith some -S H m aterial in the cell and th u s view ed as the converse of the radioprotecting effect show n by m any com pounds containing -SH groups.
M easurem ents bo th in laboratory anim als and patients show ed th at the o x id atio n /red u ctio n potential of tu m o u r tissues fell after injection of the radiosensitizers or some -S H com pounds, as it did after irradiation, b u t th at it rose if the anim al breath ed pure oxygen (59), and the same paper in troduced the first investigations of Synkavit labelled w ith a c a rb o n -14 atom in the m ethyl group and of a derivative labelled w ith a radioactive halogen atom .
By this tim e high specific-activity tritiu m gas was becom ing readily available so th at it becam e possible to incorporate sufficient tritiu m into the Synkavit m olecule to do d istrib u tio n studies and even conceivably to carry a therapeutic dose of radiation to the tu m o u r itself. Initial studies used non-specific tritiu m labelling or specific incorporation into position 3 of the m olecule. N eith er was satisfactory as the label becam e detached from the m olecule, jo ined the body fluids as tritiated w ater, and gave rise to unacceptable toxic side effects. A t the sam e tim e the advantages of using the arterial blood supply to b rin g the com pound m ore directly to the tu m o u r were considered (62). A fter considering the dosim etry of tritiu m in some detail, he suggested th a t th erap eu tic results m ight be expected if a differential absorption ratio of about 9 could be achieved and th at this m ight be reduced to about 6 if a radiosensitizer were involved.
In 1961 he published (w ith D . H . M arrian & B. M arshall) a long review on chem ical radiosensitizers including a section on the d e velopm ent of a radioactive dru g (67). By reduction of a derivative of Synkavit halogenated in position 6 of the nucleus, it was possible to produce Synkavit at a specific activity of 28 curies (Ci) m M 1 close to the theoretical m axim um required by 1 atom of tritiu m p er m olecule and, although calculations involving half-life in the tu m o u r, relative biological efficiency of tritiu m and differential absorption into tu m o u r tissue suggested th at a therapeutic dose was unlikely to be achieved, it was th o u g h t w orthw hile to give in tra-arterial injections of up to 6 Ci per 70 kg body m ass of the dru g to patients for w hom no alternative treatm en t was possible. W hen m aterial containing only firm ly b o und tritiu m was used, few if any side effects were noted and evidence of differential uptake obtained. A n interesting side investigation showed th at tum o u rs in dogs and cats, know n to be resistant to conventional radiotherapy, all show ed tem porary tu m o u r regression, and a carcinom a of the tongue of a cat regressed com pletely and had not recu rred w hen the cat died accidentally three m onths later.
L ater preparations produced com pounds having 2, 3 or 4 atom s of tritiu m per m olecule, the m ost satisfactory being 2 w hich was routinely p ro d u c e d at close to th e theoretical specific activity of 58 Ci m M ' 1. W ith m aterial of this activity p roblem s arose from self-radiation of the d ru g even th o u g h it was kept in solution over nitro g en at liquid nitrogen te m p e ratu res. A lth o u g h no changes could be detected by chem ical, p h ysico-chem ical or radio-chem ical analyses, som e batches of the c o m p o u n d did n o t show th e high differential abso rp tio n into cu ltu res of h u m a n m alig n an t cells com pared w ith norm al cells characteristic of 'g o o d ' batches. T h e la tte r could be given to p atien ts at doses of 10 Ci per 70 kg w ith o u t any effect on the bone m arrow or o th er radiosensitive organs (75). B ut th era p eu tic results rep o rted on 102 seriously ill patients w ere relatively m od est (76). Sim ilar conclusions w ere rep o rted later (78 80).
A lth o u g h gross tissue analyses show ed a differential uptake into tu m o u r cells taken from patients, it was obviously im p o rtan t and m ore in terestin g to stu d y the uptake by m eans of autoradiography, w hich was u n d ertak en , again on patien ts resistant to o th er form s of treatm en t ( (72) A lth o ugh tritiu m was an ideal tool for studying tu m o u r uptake and possible clinical responses, the low -energy b eta-rad iatio n could no t be used for w hole body scanning for diagnostic purposos for w hich a derivative labelled w ith iodine-131 was prep ared . In a sm all n u m b e r of cases tu m o u r localization corresponding to the know n m acroscopic d istrib u tio n of the p rim ary and m etastatic tu m o u rs was dem onstrated, alth o u g h som e puzzling discrepancies w ere no ted (90, 91).
M itchell was still engaged in fu rth erin g this approach to tu m o u r th erap y u n til shortly before his death, p u b lish in g m any papers w ith I. B row n and R. N . C arp en ter (103, 104, 106-112, 113, 115-124) on the synthesis of potential sensitizers containing io d in e -125 and, latterly, astatine-211. A nim al and in vitro studies had been succe clinical trials planned. T h e sam e radioactive atom s had also been attached to m ethylene blue (a dye know n to be preferentially absorbed by m alig n ant m elanom a cells) and prelim inary investigations started.
It has to be ad m itted th a t the clinical results of these approaches were rarely spectacular for several reasons. N ew form s of treatm en t have to be restricted to p atients for w hom no conventional treatm en t seems possible (term inally ill patients w ith w ide-spread m etastases or recu rren t and rad io resistant conditions), the response of even sim ilar conditions is w idely variable, the tu m o u rs are often necrotic w ith a poor blood supply m aking it difficult to deliver the com pound to the dividing tu m o u r cells, and the differential uptake into the tum our/cells com pared w ith nearby norm al tissue never reached a high enough figure. B ut if, in the future, these difficulties can be overcom e, the w ork of M itchell and his group will be th e base from w hich new w orkers in the field can start.
T h e p h y s i c i a n
As a clinician M itch ell's priorities in ru n n in g his d ep artm en t w ere: (i) the care of the patient, (ii) the im provem ent of treatm en ts, and (iii) teaching and research, and ju s t as he was a doctor rath er th an a professor to his patients, he regarded radiotherapists as physicians w ith a special skill in the treatm en t of cancer and not ju st as highly trained technicians.
All his patients were treated as ' whole people ' w ith th eir own unique problem s. Full histories and physical exam inations were m andatory in the departm ent, each case considered individually and appropriate action taken. T h e treatm en t m ight be surgery and radiotherapy or palliative to make the life m ore com fortable and to help patients and th eir families cope w ith a term inal illness.
H e organized his staff as a team and the twice weekly sessions, w hen all the doctors, radiographers, nurses, physicists and 'lady a lm o n ers' m et together, were a key factor in the sm ooth ru n n in g of the d ep artm en t and ensured th at there w ere no failures of com m unication. T h e sessions encouraged and produced critical com m ents and suggestions from all the participants.
H e was am ong the first to recognize the im portance of the psycho som atic aspects of cancer and to encourage research in this field. It was largely thro u g h his influence th at M rs F aith C ourtauld donated substantial funds to investigate the hum an side of cancer and founded T h e F aith C ourtauld In stitu te for H um an Studies in C ancer, at K in g 's College H ospital. T h is un it has m ade considerable contributions to the u nderstanding of the psychological aspects of cancer, and the psycho som atic com ponents of the disease are now widely recognized and taken into consideration in patient care.
Stem m ing from his early w ork at Chalk R iver he realized the long-term risks of radiation treatm en t long before they were generally accepted and its use in non-m alignant conditions, w hich was com m on practice in the 1950s, was never allowed at C am bridge. H e also recognized the great im portance of accurate record keeping. R adiotherapy patients had their own notes and a th reat to am algam ate them w ith the general hospital notes on grounds of econom y was m et by a th reat of resig n atio n ; and he certainly m eant it. Each event for a patient had to be recorded w ith the date and the initials of the clinician concerned, and a full disease index, treatm ent record and follow -up kept. T h is im p o rtan t aspect of his w ork was taken on by his wife, D r M ary M itchell, who gave devoted service, realizing how im portant accurate records were to her husband s work and how m uch could be learnt from them .
M itchell was also early in recognizing the im portance of random ized trials in assessing treatm ents of cancer. O ne of the first clinical trials of the treatm ent of early breast cancer was undertaken at C am bridge at his suggestion. T h is in sp ired fu rth e r clinical investigations and was the start of th e in tern atio n al series of trials of th e tre a tm e n t of b reast cancer ru n by th e C ancer R esearch C am paign.
It was at his suggestion th a t a lo n g -term stu d y was u n d ertak en into the fate of p atien ts w ith b reast cancer in th e C am b rid g e area over a five year p eriod. T h is p ro d u ced valuable inform atio n on th e n atu ral history of b reast cancer th a t has radically changed the m eth o d s of treatm en t. N o longer are w om en rou tin ely subjected to extensive and m u tilatin g surgery for b reast cancer.
A lth o u g h th e in stig ato r of m any o f the research projects u n d ertak en in his d e p a rtm e n t he rarely appeared on the su b seq u en t publication, being h ap p y to see a m em b er of his d e p a rtm e n t as sole author.
T h e scientific basis for his p a rticu lar in terest in radiosensitizers and radioactive dru g s has been covered in an o th er p art of this m em oir, b u t th e follow ing b rie f re p etitio n is as seen th ro u g h the eyes of one of his clinical team . M itchell realized th a t if the sensitivity of m alignant tu m o u rs to rad iatio n could be increased by even 10 % the results w ould be greatly im proved . H e hoped to find a co m p o u n d th a t w ould be selectively taken up by m alignant cells, tagged w ith a radioactive atom and so carry radiation into the m alignant cell. H e show ed th a t th ere was som e selective uptake of S ynkavit into m alignant cells and in the early days hopes ran high. A n intravenous injection w ould 'hom e i n ' on the cancer and p ro d u ce tin g lin g and discom fort at the site of the tu m o u r-it seem ed too good to be tru e. U n fo rtu n ately , the selective uptake was not of sufficient m ag n itu d e to produce the desired effect and su b seq u en t w ork on related com pounds did not produce anything w ith the req u ired tu m o u r selectivity. T h e idea was, and still is, first class and com parable tech n iq u es, w ith m onoclonal antibodies to targ et radiation, are now being developed. O nce again M itchell was far ahead of the field and w ith a little m ore luck could have m ade even greater im provem ents in the treatm en t of cancer.
It is difficult to sum m arize the im pact of his clinical work. H e b ro u g h t to his clinical practice and research an enorm ous background of scientific know ledge, w ith an u n d erstan d in g of life and death, of illness and hum an frailties, as well as great kindness. H e developed the R adiotherapy C entre at A d d en b ro o k e's H ospital, w hich was well know n in C am bridge and su rro u n d in g d istricts and w hich gave treatm en t, help and su p p o rt to th o u san d s of p atients and th e ir fam ilies. M any radiotherapists, physicists, rad io g raphers and nurses w ere trained th ere and w ere them selves responsible for diffusing his teaching to m any p arts of the w orld. As a resu lt of his w ork, treatm en ts are now given w ith m ore sym pathy and u n d erstan d in g , w ith m ore care for the p atien t as an individual and w ith g reater em phasis on scientific m ethod and intellectual honesty. In this way his am bition to im prove the treatm en t of patients will be achieved m ore th an he him self realized, for if he did no t achieve the great step forw ard for w hich he w orked so hard, th ere can be no d o u b t th at his influence has already been of enorm ous benefit to a great m any patients and a great m any m ore will be helped by the germ ination of the scientific ideas th at he sowed du rin g his lifetim e. 
